Log In
Print
BCIQ
Print
Print this Print this
 

H7N9 VLP vaccine

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionPlant-based virus-like particle (VLP) vaccine against H7N9 avian influenza virus
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsPrevent H7N9 avian influenza virus
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today